BSG and tuberous sclerosis: To investigate the impact of pEVs on TSC differentiation, TSC-like cells were treated with pEVs conjugated with antibodies against siglec-6/CD147 or isotypic antibodies during their differentiation into EVTs (TSC-EVTs).